ArticleEClinicalMedicine2022

Tocilizumab in patients hospitalised with COVID-19 pneumonia: Efficacy, safety, viral clearance, and antibody response from a randomised controlled trial (COVACTA).

Ivan O Rosas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.